Ligand profile
PFU
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: HT085_RS00140 — orotate phosphoribosyltransferase
Identifiers
Database identifiers and provenance.
- Ligand ID
PFU- PDB
3mi2- UniProt (similar protein)
P11172- Target protein
- HT085_RS00140
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 208.4
- −1 ≤ LogP ≤ 5 -2.51
- MW ≤ 500 Da 339.2
- LogP ≤ 5 -2.51
- H-bond donors ≤ 5 7
- H-bond acceptors ≤ 10 8
- Rotatable bonds ≤ 10 5
- TPSA ≤ 140 Ų 208.4
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
C([C@@H]1[C@H]([C@H]([C@@H](O1)c2c(c([nH]n2)C(=O)N)O)O)O)OP(=O)(O)OC([C@@H]1[C@H]([C@H]([C@@H](O1)c2c(c([nH]n2)C(=O)N)O)O)O)OP(=O)(O)O
InChI=1S/C9H14N3O9P/c10-9(16)4-6(14)3(11-12-4)8-7(15)5(13)2(21-8)1-20-22(17,18)19/h2,5,7-8,13-15H,1H2,(H2,10,16)(H,11,12)(H2,17,18,19)/t2-,5-,7-,8+/m1/s1InChI=1S/C9H14N3O9P/c10-9(16)4-6(14)3(11-12-4)8-7(15)5(13)2(21-8)1-20-22(17,18)19/h2,5,7-8,13-15H,1H2,(H2,10,16)(H,11,12)(H2,17,18,19)/t2-,5-,7-,8+/m1/s1
CUHDHRMGDRLFLH-FLLFQEBCSA-NCUHDHRMGDRLFLH-FLLFQEBCSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00215
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand PFU →
- PDB RCSB structure 3mi2 →
- UniProt UniProt P11172 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “PFU”) →
Other ligands for this protein
Quick navigation to other ligands bound to HT085_RS00140.
PDB 18
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 4
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).